Charged lipoprotein complexes and their uses
AssigneeCerenis Therapeutics, S.A.
InventorJean-Louis Dasseux
Life of this patent
Estimating the term…
Abstract
The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
Claims60
A reconstituted charged lipoprotein complex comprising an apolipoprotein fraction and a lipid fraction, wherein said lipid fraction comprises a neutral phospholipid and about 0.2 to 3 wt % of a charged phospholipid.
A reconstituted charged lipoprotein complex comprising an apolipoprotein fraction and a lipid fraction, wherein said lipid fraction consists essentially of a lecithin, a sphingomyelin and about 1 to 10 wt % of a charged phospholipid.
Dependencies are inferred from the claim text.